105 related articles for article (PubMed ID: 6291006)
1. Tumor marker production in human bronchial carcinoma xenografts.
Shorthouse AJ; Carter SM; Ellison ML
Oncodev Biol Med; 1982; 3(4):273-81. PubMed ID: 6291006
[TBL] [Abstract][Full Text] [Related]
2. Differential behavior of human bronchial carcinoma cells in culture.
Klein JC; Zurcher C; van Bekkum DW
Cancer Res; 1987 Jun; 47(12):3251-8. PubMed ID: 3034407
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
4. Xenografts of human bladder cancer in immune-deprived mice.
Kovnat A; Armitage M; Tannock I
Cancer Res; 1982 Sep; 42(9):3696-703. PubMed ID: 7049361
[TBL] [Abstract][Full Text] [Related]
5. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
6. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
Kovnat A; Khoo K; Selby P; Tannock I
Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison.
Shorthouse AJ; Peckham MJ; Smyth JF; Steel GG
Br J Cancer Suppl; 1980 Apr; 4():142-5. PubMed ID: 6252930
[TBL] [Abstract][Full Text] [Related]
8. Nude mouse xenografts as in vivo models for lung carcinomas.
Bepler G; Neumann K
In Vivo; 1990; 4(5):309-15. PubMed ID: 1966790
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts.
Bak M; Mattern J; Volm M
In Vivo; 1987; 1(5):319-26. PubMed ID: 2485134
[TBL] [Abstract][Full Text] [Related]
10. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of four new human non-small cell lung cancer cell lines.
Loh PM; Clamon GH; Robinson RA; White ML; Hukku B; Rossi NP; Peterson WD
Cancer Res; 1984 Aug; 44(8):3561-9. PubMed ID: 6744280
[TBL] [Abstract][Full Text] [Related]
12. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer.
Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ
In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035
[TBL] [Abstract][Full Text] [Related]
13. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
14. Cell biologic properties in explant culture and heterotransplantation of malignant uterine cervical cells.
Ishiwata I; Ishiwata C; Soma M; Nozawa S; Ishikawa H
Acta Cytol; 1987; 31(6):925-34. PubMed ID: 3425154
[TBL] [Abstract][Full Text] [Related]
15. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
Liu C; Tsao MS
Am J Pathol; 1993 Feb; 142(2):413-23. PubMed ID: 8382008
[TBL] [Abstract][Full Text] [Related]
16. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF
Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
[TBL] [Abstract][Full Text] [Related]
17. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
18. [Biological and morphologic study of human bronchial carcinoma xenografts].
Bak M; Oláh E; Gaál D; Pokorny E; Sugár J
Morphol Igazsagugyi Orv Sz; 1984 Jul; 24(3):171-9. PubMed ID: 6090890
[No Abstract] [Full Text] [Related]
19. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration.
Słodkowska J; Szturmowicz M; Giedronowicz D; Rudzinski P; Sakowicz A; Kupis W
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
